23andMe is currently trading at around $3.15, down from more than $18 at the start of the year and more than $200 on its debut. Last week, 23andMe announced sweeping job losses affecting around 40 ...

23andMe CEO Anne Wojcicki knows the genetic-testing and ancestry-tracing company has been in "the eye of the storm" recently, but she said she's confident that the company is still viable and ...

23andMe CEO Anne Wojcicki discusses the company's future following a major data security incident that led to a $30 million ...

Anne Wojcicki wanted to run things—alone. It was 2009 and her startup 23andMe was riding high, fueled by a steady stream of venture money, intriguing personal accounts of genome exploration ...

23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs. The latest ...

More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...

US-based genetic analysis start-up 23andMe reported a drop in revenue in its latest quarter – on Tuesday, a day after the company announced it was laying off forty percent of its workforce and ...

death Private prison stocks soar after Trump names Tom Homan 'border czar' While 23andMe shares are down about 75% since the start of the year, the company's stock jumped more than 5% in after ...

The shifting economic systems and unpredictable labor market have had an effect on the most unexpected of industries. Genetic testing company 23andMe has announced layoffs at its organization, with ...